Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 07 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding a recent USFDA inspection. The inspection at their formulation manufacturing facility in Ahmedabad concluded with no observations. This announcement serves as a disclosure in accordance with regulatory requirements.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated July 07, 2023, titled "USFDA inspection at Zydus formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations".

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases